Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia

Haematologica. 2022 Jun 1;107(6):1448-1453. doi: 10.3324/haematol.2021.278913.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Interferons*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • T-Lymphocytes

Substances

  • Interferons

Grants and funding

Funding: This work was supported by the Stichting ME TO YOU, the Ghent University Research Fund (BOF-UGent) and the Research Foundation Flanders (FWO).